 |
InterPro: IPR001093 IMP dehydrogenase/GMP reductase
Protein matches
|
UniProtKB Matches: 2802 proteins |
|
Accession
|
IPR001093 IMP_DH_GMPRt |
Type
|
Family |
Signatures
|
|
InterPro Relationships
|
|
Parent
|
IPR013785 Aldolase-type TIM barrel
|
|
Children
|
IPR005992 IMP dehydrogenase related 2
IPR005993 Guanosine monophosphate reductase 1
IPR005994 Guanosine monophosphate reductase 2
IPR018529 IMP dehydrogenase related
|
|
Contains
|
IPR000644 Cystathionine beta-synthase, core
IPR015875 IMP dehydrogenase / GMP reductase, conserved site
|
GO Term annotation
|
|
Process
|
GO:0055114 oxidation reduction
|
|
Function
|
GO:0003824 catalytic activity
|
|
InterPro annotation
|
|
Entry Details in BioMart
|
Abstract
|
Synonym(s): Inosine-5'-monophosphate dehydrogenase, Inosinic acid dehydrogenase;
Synonym(s): Guanosine 5'-monophosphate oxidoreductase
This entry contains two related enzymes IMP dehydrogenase and GMP reducatase. These enzymes adopt a TIM barrel structure.
IMP dehydrogenase (EC:1.1.1.205) (IMPDH) catalyzes the rate-limiting reaction of de novo GTP biosynthesis, the NAD-dependent reduction of IMP into XMP [1].
Inosine 5-phosphate + NAD+ + H2O = xanthosine 5-phosphate + NADH
IMP dehydrogenase is associated with cell proliferation and is a possible target for cancer chemotherapy. Mammalian and bacterial IMPDHs are tetramers of identical chains. There are two IMP dehydrogenase isozymes in humans [2]. IMP dehydrogenase nearly always contains a long insertion that has two CBS domains within it.
GMP reductase (EC:1.7.1.7) catalyzes the irreversible and NADPH-dependent reductive deamination of GMP into IMP [3].
NADPH + guanosine 5-phosphate = NADP+ + inosine 5-phosphate + NH3
It converts nucleobase, nucleoside and nucleotide derivatives of G to A nucleotides, and maintains intracellular balance of A and G nucleotides.
|
Structural links
|
|
Database links
|
Pfam Clan: CL0036.20
|
Additional Reading
|
|
Zhang R, Evans G, Rotella FJ, Westbrook EM, Beno D, Huberman E, Joachimiak A, Collart FR.
Characteristics and crystal structure of bacterial inosine-5'-monophosphate dehydrogenase.
Biochemistry 38 1999 4691-700
[PubMed: 10200156]
http://dx.doi.org/10.1021/bi982858v
|
|
McMillan FM, Cahoon M, White A, Hedstrom L, Petsko GA, Ringe D.
Crystal structure at 2.4 A resolution of Borrelia burgdorferi inosine 5'-monophosphate dehydrogenase: evidence of a substrate-induced hinged-lid motion by loop 6.
Biochemistry 39 2000 4533-42
[PubMed: 10758003]
http://dx.doi.org/10.1021/bi992645l
|
|
Gan L, Petsko GA, Hedstrom L.
Crystal structure of a ternary complex of Tritrichomonas foetus inosine 5'-monophosphate dehydrogenase: NAD+ orients the active site loop for catalysis.
Biochemistry 41 2002 13309-17
[PubMed: 12403633]
http://dx.doi.org/10.1021/bi0203785
|
|
Whitby FG, Luecke H, Kuhn P, Somoza JR, Huete-Perez JA, Phillips JD, Hill CP, Fletterick RJ, Wang CC.
Crystal structure of Tritrichomonas foetus inosine-5'-monophosphate dehydrogenase and the enzyme-product complex.
Biochemistry 36 1997 10666-74
[PubMed: 9271497]
http://dx.doi.org/10.1021/bi9708850
|
|
Gan L, Seyedsayamdost MR, Shuto S, Matsuda A, Petsko GA, Hedstrom L.
The immunosuppressive agent mizoribine monophosphate forms a transition state analogue complex with inosine monophosphate dehydrogenase.
Biochemistry 42 2003 857-63
[PubMed: 12549902]
http://dx.doi.org/10.1021/bi0271401
|
|
Prosise GL, Luecke H.
Crystal structures of Tritrichomonasfoetus inosine monophosphate dehydrogenase in complex with substrate, cofactor and analogs: a structural basis for the random-in ordered-out kinetic mechanism.
J. Mol. Biol. 326 2003 517-27
[PubMed: 12559919]
http://dx.doi.org/10.1016/S0022-2836(02)01383-9
|
|
Prosise GL, Wu JZ, Luecke H.
Crystal structure of Tritrichomonas foetus inosine monophosphate dehydrogenase in complex with the inhibitor ribavirin monophosphate reveals a catalysis-dependent ion-binding site.
J. Biol. Chem. 277 2002 50654-9
[PubMed: 12235158]
http://dx.doi.org/10.1074/jbc.M208330200
|
|
|
InterPro 23.1
|